Oral Gabapentin in the Treatment of Carpal Tunnel Syndrome
Status:
Not yet recruiting
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
In the present investigation the pain reduction effects of Gabapentin will be compared to
those produced by the absence of treatment, in subjects who suffer the signs and symptoms of
carpal tunnel syndrome.